Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 6,231 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their
Pipelines (selected by target, therapeutic area, company, technology)
Sales (for marketed antibodies)
R&D Phase (clinical phases, market, preclinical)
Territory (countrywise)
Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
Drug Code/Name (for individual molecules)
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
Antibody-Drug Conjugates
Bispecific Antibodies
Vectorized Antibodies (in vivo expression)
Masked Antibodies
TCR-like Antibodies
T-Cell Engaging Antibodies
Natural Killer (NK) Cell Engaging Antibodies
Biosimilar and Biosuperior Antibodies
Sales Data of more than 120 therapeutic antibodies (incl. sales history)
Prerequisite: Internet access.
Purchase of the subscription provides a 1-year online access to the data of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the Antibody Pipeline Database:
Intuitive use
Designed for structured searches
Focused on targets, therapeutic areas and R&D phases
Ideal for competitor analysis (companies, targets, technologies, R&D phase)
Cost-effective and rapid solution for benchmarking
Identification of licensing candidates
Project listing in a tabular format:
Drug Codes
Target
Class of Compound
Company
Territory
Therapeutic Area
Indication
R&D Phase
Therapeutic Areas:
Cardiovascular & blood
Dermatology
Gastrointestinal
Genitourinary, renal & gynecology
Infectious & toxicology
Metabolism & endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhinolaryngology
Orthopedics, dental, anesthesia & surgery
Pulmonary & respiratory
Rheumatoid & autoimmune
Predefined Technologies Scroll-Down Menu - examples:
Antibody-Drug Conjugates per Payload (e.g. Auristatin, PBD)
Bispecific Antibodies
Oligo- and Polyclonal Antibodies
In vitro generated Antibodies (phage display)
Fab Antibodies
Fc-Fusion Proteins
Agonist Antibodies
Transgenic Mouse Antibodies (e.g. XenoMouse, VelocImmune Mouse, KM Mouse)
Human Cell-Derived Antibodies
Predefined Targets of the Scroll Down Menu - examples: